Haleon plc (LON:HLN) Insider Dawn Allen Sells 74,679 Shares

Haleon plc (LON:HLN - Get Free Report) insider Dawn Allen sold 74,679 shares of the firm's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.66), for a total transaction of £277,805.88 ($348,258.59).

Haleon Stock Up 2.1 %

Shares of LON:HLN traded up GBX 7.90 ($0.10) during midday trading on Friday, reaching GBX 380.30 ($4.77). The company's stock had a trading volume of 12,083,517 shares, compared to its average volume of 19,651,047. Haleon plc has a 12-month low of GBX 308.37 ($3.87) and a 12-month high of GBX 400.65 ($5.02). The firm has a market capitalization of £34.38 billion, a P/E ratio of 3,169.17, a PEG ratio of 1.49 and a beta of 0.19. The firm has a 50 day moving average of GBX 379.25 and a 200-day moving average of GBX 357.45. The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 54.18.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank boosted their price objective on shares of Haleon from GBX 410 ($5.14) to GBX 447 ($5.60) and gave the company a "buy" rating in a research report on Monday, August 5th.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.